Developmental reprogramming underlies chemotherapy resistance in favorable-histology Wilms tumor
Andrew M. Fleming(University of Tennessee Health Science Center), Andrew J. Murphy(St. Jude Children's Research Hospital), Anthony A. High(St. Jude Children's Research Hospital), Geoffrey Neale(St. Jude Children's Research Hospital), Jerold E. Rehg(St. Jude Children's Research Hospital), Karissa M. Dieseldorff Jones(St. Jude Children's Research Hospital), Prahalathan Pichavaram(St. Jude Children's Research Hospital), Ha Won Lee(St. Jude Children's Research Hospital), John Easton(St. Jude Children's Research Hospital), Changde Cheng(St. Jude Children's Research Hospital), Gerard P. Zambetti(St. Jude Children's Research Hospital), Emília M. Pinto(St. Jude Children's Research Hospital), Carolyn M. Jablonowski(St. Jude Children's Research Hospital), Deidre Daria(St. Jude Children's Research Hospital), Teresa Santiago(St. Jude Children's Research Hospital), Vishwajeeth Pagala(St. Jude Children's Research Hospital), Christopher L. Morton(St. Jude Children's Research Hospital), Mary A. Woolard(St. Jude Children's Research Hospital), Daniel B. Gehle(St. Jude Children's Research Hospital), Jake C. Harbour(St. Jude Children's Research Hospital), Surbhi Sona(St. Jude Children's Research Hospital), Laura J. Janke(St. Jude Children's Research Hospital), Virginia Valentine(St. Jude Children's Research Hospital), Beisi Xu(St. Jude Children's Research Hospital), Siwei Zhang(Northwestern University), Xiaotu Ma(St. Jude Children's Research Hospital), Steven Burden(St. Jude Children's Research Hospital), Scott R. Olsen(St. Jude Children's Research Hospital), Kiran Kodali(St. Jude Children's Research Hospital), Taosheng Chen(St. Jude Children's Research Hospital), Andrew M. Davidoff(St. Jude Children's Research Hospital), Hongjian Jin(St. Jude Children's Research Hospital), Gang Wu(St. Jude Children's Research Hospital), Xiang Chen(St. Jude Children's Research Hospital), Ti-Cheng Chang(St. Jude Children's Research Hospital), Daniel Vocelle(St. Jude Children's Research Hospital), Yogesh Kumar(St. Jude Children's Research Hospital), Sivaraman Natarajan(St. Jude Children's Research Hospital), Jun Yang(St. Jude Children's Research Hospital), Rani E. George(Dana-Farber/Boston Children's Cancer and Blood Disorders Center)
Cited by 1
Related Papers
HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
|The Journal of Experimental Medicine|2011|1.8k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Germline Mutations in Predisposition Genes in Pediatric Cancer
|New England Journal of Medicine|2015|1.4k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934